Literature DB >> 28252245

A Population-Based Cross-Sectional Study Comparing Breast Cancer Stage at Diagnosis between Immigrant and Canadian-Born Women in Ontario.

Javaid Iqbal1, Ophira Ginsburg1,2, Hadas D Fischer3, Peter C Austin3,4, Maria I Creatore5, Steven A Narod1,2, Paula A Rochon1,3,4.   

Abstract

There is limited information on stage at breast cancer diagnosis in Canadian immigrant women. We compared stage at diagnosis between immigrant women and Canadian-born women, and determined whether ethnicity was an independent factor associated with stage. 41,213 women with invasive breast cancer from 2007 to 2012 were identified from the Ontario Cancer Registry. Women were classified as either immigrants or Canadian-born by linkage with the Immigration, Refugees, and Citizenship Canada's Permanent Resident database. Women's ethnicity was classified as Chinese, South Asian, or remaining women in Ontario. Logistic regression was performed to calculate the odds ratio (OR) of being diagnosed at stage I breast cancer (versus stage II-IV). 4,353 (10.6%) women were immigrants and 36,860 (89.4%) were Canadian-born women. The mean age at breast cancer diagnosis was 53.5 years for immigrants versus 62.3 years for Canadian-born women (p < 0.0001). Immigrant women were less likely than Canadian-born women to be diagnosed with stage I breast cancers (adjusted OR = 0.85; 95% CI: 0.79-0.91; p < 0.0001). The adjusted OR of being stage I was 1.28 (95% CI: 1.14-1.43; p < 0.0001) for women of Chinese ethnicity and was 0.82 (95% CI: 0.70-0.96; p = 0.01) for women of South Asian ethnicity, compared to the remaining women in Ontario. Canadian immigrant women were less likely than Canadian-born women to be diagnosed with early-stage breast cancers. Ethnicity was a greater contributor to the stage disparity than was immigrant status. South Asian women, regardless of immigration status, might benefit from increased breast cancer awareness programs.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  breast cancer; canadian-born; immigrant; stage at diagnosis

Mesh:

Year:  2017        PMID: 28252245     DOI: 10.1111/tbj.12785

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  7 in total

1.  First Prospective Cross-Sectional Study on the Impact of Immigration Background and Education in Early Detection of Breast Cancer.

Authors:  Elna Kuehnle; Wulf Siggelkow; Kristina Luebbe; Iris Schrader; Karl-Heinz Noeding; Stefanie Noeding; Thomas Noesselt; Peter Hillemanns; Thilo Dörk; Tjoung-Won Park-Simon
Journal:  Breast Care (Basel)       Date:  2020-11-24       Impact factor: 2.268

2.  Breast cancer awareness among Afghan refugee women in Turkey.

Authors:  Mehmet Celal Kizilkaya; Sarah Sabrine Kilic; Mehmet Abdussamet Bozkurt; Osman Sibic; Nisha Ohri; Meredith Faggen; Laura Warren; Julia Wong; Rinaa Punglia; Jennifer Bellon; Bruce Haffty; Mutlay Sayan
Journal:  EClinicalMedicine       Date:  2022-06-03

3.  Who is Black? The urgency of accurately defining the Black population when conducting health research in Canada.

Authors:  Jude Mary Cénat
Journal:  CMAJ       Date:  2022-07-18       Impact factor: 16.859

4.  Breast screening participation and retention among immigrants and nonimmigrants in British Columbia: A population-based study.

Authors:  Ryan R Woods; Kimberlyn M McGrail; Erich V Kliewer; Arminee Kazanjian; Colin Mar; Lisa Kan; Janette Sam; John J Spinelli
Journal:  Cancer Med       Date:  2018-07-09       Impact factor: 4.452

5.  Breast Cancer Characteristics in Middle Eastern Women Immigrants Compared With Non-Hispanic White Women in California.

Authors:  Clara Ziadeh; Argyrios Ziogas; Luohua Jiang; Hoda Anton-Culver
Journal:  JNCI Cancer Spectr       Date:  2018-05-30

6.  Primary Care Continuity and Wait Times to Receiving Breast Cancer Chemotherapy: A Population-Based Retrospective Cohort Study Using CanIMPACT Data.

Authors:  Rachel Lin Walsh; Aisha Lofters; Rahim Moineddin; Monika Krzyzanowska; Eva Grunfeld
Journal:  Curr Oncol       Date:  2021-11-17       Impact factor: 3.677

7. 

Authors:  Jude Mary Cénat
Journal:  CMAJ       Date:  2022-09-19       Impact factor: 16.859

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.